Here are the latest updates on the COVID-19 vaccine distribution
This is our continuing coverage of the steps being taken to get every American inoculated against the coronavirus.
More than half of Americans have gotten at least their first COVID-19 shot and vaccinations are now open to those 16 and older nationwide.
Over 110 million doses of the Pfizer vaccine have been administered; over 93 million of the Moderna vaccine; and over 7 million of the Johnson & Johnson vaccine, according to data from the Centers for Disease Control and Prevention.
The J&J vaccine continues to be on pause as the CDC and the Food and Drug Administration review reports of six women having developed blood clots after receiving the vaccine.
J&J said a study showed issues with blood clots with the Moderna and Pfizer vaccines. But according to the same study's lead author, Dr. Eun-Ju Lee, none of these things were happening with the Moderna and Pfizer vaccines, according to CNN.
The study, published February 19, said there were 20 patients who were hospitalized with thrombocytopenia, or low blood platelet count, within 1-23 days after vaccination of the Pfizer or Moderna vaccine.
Johson & Johnson reported strong first quarter earnings today, with a 6.9% increase in net earnings over the first quarter of 2020. Results were driven by its pharmaceutical business and continued recovery in medical devices, according to Alex Gorsky, chairman and CEO.
See our continuing vaccine coverage here:
A look at the pandemic's effect on supply chain, with McKesson's Craig Dolan
Pfizer releases new vaccine efficacies, while J&J vaccine shipments get delayed
Vaccines and prior COVID-19 infection offer protection against variants
AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial
AstraZeneca vaccine shows 79% efficacy in phase III trial
Providers get greater reimbursement for COVID-19 vaccine
Big shift seen in high-risk older adults' attitudes toward COVID-19 vaccination
CVS Health expands COVID-19 vaccine offerings to 29 states
CDC relaxes COVID-19 restrictions as more Americans get vaccinated
$250 million in COVID-19 grants aim to vaccinate underserved populations
Health insurers commit to helping seniors receive the COVID-19 vaccine
Merck to open facilities to Johnson & Johnson for speedier COVID-19 vaccine production
FDA issues emergency use authorization for Johnson & Johnson COVID-19 vaccine
Biden signs executive order to spur domestic supply chain
Human rights law can provide a fair, transparent framework for vaccine allocations
FDA deems Johnson & Johnson COVID-19 vaccine safe and effective
CVS Health to expand vaccine efforts in Florida
CVS Health, Lyft and YMCA team for equitable access to a COVID-19 vaccination site
AHIP launches resource page dedicated to COVID-19 vaccines
New COVID-19 model shows little benefit in vaccinating high-risk individuals first
Biden issues 5 executive orders to ramp up COVID-19 vaccine and supply response
Federal government tells states not to hold vaccine in reserve for second dose
HHS releases $22 billion for testing and vaccinations
AHA urges HHS to better coordinate COVID-19 vaccine rollout
CVS Health administering COVID-19 vaccine at skilled nursing facilities in 49 states
Moderna vaccine shows 94.1% efficacy in a Phase 3 clinical trial
Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
Confusion about flu shot, efficacy of COVID-19 vaccines may slow adoption
Smart temp control technology could be key for COVID-19 vaccine rollout
CareFirst BlueCross BlueShield to cover all costs for COVID-19 vaccines
U.S. government agrees to purchase 100 million additional Pfizer vaccines
Close to 8 million doses of two COVID-19 vaccines are going out this week
Moderna vaccine rolls out amid miscommunication over Pfizer doses and new virus strain
Walgreens begins administering the COVID-19 vaccine in select states
FDA advisory committee approves Moderna vaccine for emergency use authorization
FDA advisory committee today is expected to scrutinize Moderna on vaccine reaction
Pharmacy giants ramp up logistical assistance for COVID-19 vaccine rollout
CDC is giving $227 million for COVID-19 vaccine preparedness and tracking
More than half unlikely to get COVID-19 vaccine under emergency use authorization
HHS purchases 100 million additional doses of Moderna investigational COVID-19 vaccine
Pfizer-BioNTech vaccine rolls out to frontline healthcare workers
FDA to 'rapidly work' towards emergency use authorization for Pfizer-BioNTech vaccine
Pfizer-BioNTech vaccine gets FDA advisory committee approval
Thousands in the United Kingdom are the first to receive Pfizer COVID-19 vaccine
Eli Lilly and UnitedHealth Group partner on COVID-19 antibody treatment for high-risk individuals
Operation Warp Speed is looking to start distributing COVID-19 vaccine by mid-month
Moderna seeks regulatory authorization for its COVID-19 vaccine
HHS will begin allocating Regeneron's COVID-19 therapeutic this week
HHS partners with chain and independent pharmacies to increase access to future COVID-19 vaccines
COVID-19 vaccine distribution will begin within 24 hours of an emergency use authorization
Moderna vaccine candidate shows 94.5% efficacy against COVID-19
Pfizer touts new COVID-19 vaccine, calling it '90% effective'
Medicare beneficiaries can get monoclonal antibody COVID-19 treatments at no cost
FDA grants emergency use authorization for Eli Lilly antibody treatment for COVID-19
Twitter: @SusanJMorse
Email the writer: susan.morse@himssmedia.com
